BRIEF published on 09/15/2026 at 18:05, 1 day 20 hours ago Ateme makes available the 2026 half-year financial report AMF Financial Report Financial Documents ATEME Semester 2026
BRIEF published on 09/10/2026 at 17:50, 6 days 21 hours ago ATEME: 2026 Half-Year Results Show Significant Improvement EBITDA Technological Innovation Half-year Results Financial Growth ATEME
BRIEF published on 09/10/2026 at 17:50, 6 days 21 hours ago Ateme Reports Strong Financial Performance in H1 2026 Revenue Growth Financial Performance EBITDA Margin Technology Innovations Regional Revenue
PRESS RELEASE published on 09/10/2026 at 17:45, 6 days 21 hours ago FIRST HALF 2026 RESULTS Ateme reports strong financial performance with revenues up 25% like-for-like, gross profit up 22% and EBITDA of €6.3 million, an increase of €4.8 million year-on-year. Financial statements for the Six Months to June 30th, 2026 have been approved Revenues EBITDA Financial Performance Growth ATEME
BRIEF published on 09/08/2026 at 17:50, 8 days 21 hours ago Publication of voting rights and shares of Ateme as of September 7, 2026 Share Capital Voting Rights Investment Legal Thresholds Ateme Actions
BRIEF published on 07/17/2026 at 17:50, 1 month 30 days ago ATEME recorded a 29% increase in the second quarter of 2026 North America Video Technology Quarterly Growth Monthly Recurring Income ATEME Strategy
BRIEF published on 07/17/2026 at 17:50, 1 month 30 days ago ATEME Reports Significant Revenue Growth in First Half of 2026 Revenue Growth Video Technology Regional Performance Market Positioning MRR Increase
PRESS RELEASE published on 07/17/2026 at 17:45, 1 month 30 days ago SECOND QUARTER AND FIRST HALF 2026 REVENUES Ateme reports strong financial performance in Q2 2026 with 29% revenue growth (+34% like-for-like). H1 2026 revenues up 20% (+25% like-for-like). MRR increased by 20% year-on-year and 4% sequentially Revenue Growth Financial Performance Innovative Solutions ATEME MRR Increase
BRIEF published on 07/03/2026 at 18:05, 2 months 13 days ago Ateme's half-yearly liquidity contract review as of June 30, 2026 Liquidity Transactions Paris ATEME Walk
BRIEF published on 06/09/2026 at 08:35, 3 months 8 days ago Apple Highlights Ateme at WWDC26 Video Compression Apple WWDC26 Ateme Solution Immersive Workflows Ad Insertion
Published on 09/17/2026 at 14:50, 10 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 14:47, 13 minutes ago Nextech3D.ai Announces CEO Evan Gappelberg Acquires 7.4 Million Shares
Published on 09/17/2026 at 14:31, 29 minutes ago First Breach Announces Three-Year Ammunition Supply and Distribution Agreement with SAS Ammo
Published on 09/17/2026 at 13:30, 1 hour 30 minutes ago UniDoc Health Equips San Juan, Puerto Rico Ambulances With Live Patient Video
Published on 09/17/2026 at 13:30, 1 hour 30 minutes ago Electric Royalties Reports Permitting Progress and New Exploration Results Across Critical Metals Royalty Portfolio
Published on 09/17/2026 at 14:35, 24 minutes ago Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $380 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens
Published on 09/17/2026 at 14:30, 29 minutes ago Hong Kong sets out strategic vision for developing the Northern Metropolis and creating a global talent hub
Published on 09/17/2026 at 13:25, 1 hour 34 minutes ago Custodian Property Income REIT plc: Results of Annual General Meeting
Published on 09/17/2026 at 13:25, 1 hour 34 minutes ago CDTL Highlights E-Drive + EMB Technologies for Commercial Vehicles at IAA Transportation 2026
Published on 09/17/2026 at 13:25, 1 hour 34 minutes ago ATOME PLC: Notice of Dispute and Intent to Submit Claim to Arbitration under the UK - Paraguay Bilateral Investment Treaty ("the Treaty" or "BIT")
Published on 09/16/2026 at 17:45, 21 hours 15 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 8 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 21 hours ago Report on the Combined General Meeting of the 10th of September 2026
